English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Open clinical trial on the sigma ligand panamesine in patients with schizophrenia

MPS-Authors
/persons/resource/persons80453

Murck,  H.
AG Steiger, Axel, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80372

Holsboer,  F.
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80541

Steiger,  A.
AG Steiger, Axel, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Frieboes, R.-M., Murck, H., Wiedemann, K., Holsboer, F., & Steiger, A. (1997). Open clinical trial on the sigma ligand panamesine in patients with schizophrenia. Psychopharmacology, 132, 82-88.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-A9AE-5
Abstract
There is no abstract available